Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up
β Scribed by A. KOHN; M. DAPERNO; A. ARMUZZI; M. CAPPELLO; L. BIANCONE; A. ORLANDO; A. VISCIDO; V. ANNESE; G. RIEGLER; G. MEUCCI; M. MARROLLO; R. SOSTEGNI; A. GASBARRINI; S. PERALTA; C. PRANTERA
- Book ID
- 108605045
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 507 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: We have developed a technique for measuring fecal excretion of human dna by assuming that luminal desquamation of epithelial and inflammatory cells increases in damaged colonic mucosa. however, the clinical usefulness of this technique in the follow-up of patients with ulcerative col
## Abstract ## BACKGROUND Patients with aggressive nonβHodgkin lymphoma (NHL) require intensive and extensive therapy, which seems impracticable in elderly patients due to hematologic and extrahematologic toxicity. Consequent dose reduction and therapy attenuation can reduce treatmentβrelated toxi